🇺🇸 FDA
Patent

US 7732470

Compositions and methods for the treatment of renal and cardiovascular disease

granted A61KA61K31/198A61P

Quick answer

US patent 7732470 (Compositions and methods for the treatment of renal and cardiovascular disease) held by The Board of Regents of the University of Texas System expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/198, A61P, A61P3/10, A61P9/10